ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,598,684 | -68.1% | 279,981 | -63.9% | 0.00% | -50.0% |
| Q2 2023 | $23,850,305 | -45.5% | 775,872 | -36.2% | 0.00% | -60.0% |
| Q1 2023 | $43,789,205 | +79.2% | 1,215,354 | +96.5% | 0.01% | +66.7% |
| Q4 2022 | $24,440,749 | +1.7% | 618,440 | +3.4% | 0.01% | 0.0% |
| Q3 2022 | $24,030,000 | +7.4% | 598,061 | +12.3% | 0.01% | 0.0% |
| Q2 2022 | $22,384,000 | -66.5% | 532,445 | -68.9% | 0.01% | -57.1% |
| Q1 2022 | $66,744,000 | +418.9% | 1,713,133 | +430.7% | 0.01% | +366.7% |
| Q4 2021 | $12,863,000 | +48.1% | 322,781 | +34.3% | 0.00% | +50.0% |
| Q3 2021 | $8,687,000 | -68.8% | 240,379 | -64.6% | 0.00% | -66.7% |
| Q2 2021 | $27,834,000 | +101.2% | 679,051 | +114.1% | 0.01% | +100.0% |
| Q1 2021 | $13,836,000 | -53.1% | 317,205 | -46.2% | 0.00% | -62.5% |
| Q4 2020 | $29,497,000 | +514.4% | 589,341 | +416.3% | 0.01% | +700.0% |
| Q3 2020 | $4,801,000 | -89.5% | 114,149 | -87.9% | 0.00% | -93.8% |
| Q2 2020 | $45,729,000 | – | 941,905 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |